Rain Therapeutics Correlations
| RAINDelisted Stock | USD 1.41 0.01 0.70% |
The current 90-days correlation between Rain Therapeutics and AVROBIO is 0.17 (i.e., Average diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Rain Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Rain Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction.
Rain Therapeutics Correlation With Market
Significant diversification
The correlation between Rain Therapeutics and DJI is 0.05 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Rain Therapeutics and DJI in the same portfolio, assuming nothing else is changed.
Rain |
Moving together with Rain Stock
| 0.63 | VFSWW | VinFast Auto | PairCorr |
| 0.71 | EC | Ecopetrol SA ADR | PairCorr |
| 0.62 | TLK | Telkom Indonesia Tbk | PairCorr |
| 0.73 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
| 0.63 | JNJ | Johnson Johnson Fiscal Year End 28th of January 2025 | PairCorr |
Moving against Rain Stock
| 0.84 | CAT | Caterpillar Fiscal Year End 3rd of February 2025 | PairCorr |
| 0.84 | AA | Alcoa Corp Fiscal Year End 15th of January 2025 | PairCorr |
| 0.8 | HPQ | HP Inc | PairCorr |
| 0.79 | CSCO | Cisco Systems Aggressive Push | PairCorr |
| 0.72 | XOM | Exxon Mobil Corp Sell-off Trend | PairCorr |
| 0.72 | AXP | American Express Fiscal Year End 24th of January 2025 | PairCorr |
| 0.67 | CVX | Chevron Corp Fiscal Year End 7th of February 2025 | PairCorr |
| 0.64 | WMT | Walmart Aggressive Push | PairCorr |
| 0.56 | BAC | Bank of America Fiscal Year End 10th of January 2025 | PairCorr |
| 0.53 | KB | KB Financial Group | PairCorr |
| 0.53 | TRV | The Travelers Companies Fiscal Year End 17th of January 2025 | PairCorr |
| 0.5 | JPM | JPMorgan Chase Fiscal Year End 10th of January 2025 | PairCorr |
| 0.5 | MCD | McDonalds Fiscal Year End 3rd of February 2025 | PairCorr |
| 0.48 | IBM | International Business Fiscal Year End 22nd of January 2025 | PairCorr |
| 0.32 | VFS | VinFast Auto Earnings Call Tomorrow | PairCorr |
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Rain Stock performing well and Rain Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Rain Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| AVRO | 1.77 | 0.18 | 0.01 | (0.49) | 1.89 | 4.11 | 14.20 | |||
| CWBR | 7.34 | 2.25 | 0.33 | 1.40 | 5.34 | 5.73 | 250.97 | |||
| OCEA | 3.56 | (0.56) | 0.00 | (1.39) | 0.00 | 7.46 | 28.33 | |||
| ENVB | 3.22 | (0.65) | 0.00 | (2.30) | 0.00 | 6.25 | 28.33 | |||
| ELEV | 3.51 | (0.59) | 0.00 | (0.17) | 0.00 | 5.77 | 22.21 | |||
| HEPA | 3.82 | (0.35) | 0.00 | (0.15) | 0.00 | 8.06 | 33.54 | |||
| ZURA | 3.89 | (0.50) | 0.00 | (0.15) | 0.00 | 7.95 | 30.69 | |||
| EFTR | 7.57 | (4.50) | 0.00 | 8.68 | 0.00 | 8.70 | 88.91 |
Rain Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Rain Therapeutics stock to make a market-neutral strategy. Peer analysis of Rain Therapeutics could also be used in its relative valuation, which is a method of valuing Rain Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Rain Therapeutics Corporate Management
| Josephine Bruce | Principal officer | Profile | |
| Richard Bryce | Ex Officer | Profile | |
| Vijaya Tirunagaru | Senior Research | Profile | |
| Lucio Tozzi | VP Operations | Profile | |
| Nora MD | MD Development | Profile | |
| Nelson Cabatuan | Sr Admin | Profile | |
| Avanish MBA | CEO CoFounder | Profile |
Still Interested in Rain Therapeutics?
Investing in delisted delisted stocks can be risky, as the stock is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.